• Depleted SOX-2 via targeting the FBXW2-MSX2 axis• Suppressed CSC properties• Sensitized breast cancer cells to tamoxifen• Combination with 5-AZA increased DNA-damage, cell death and complete xenograft tumor regression. This evidence concerns the gene SOX2 and breast cancer.